Maya Kotturi
6Patents
2h-index
27Co-inventors
43Inventor score
Filing activity: Aug 17, 2017 → Dec 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10124061B2 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US10751415B2 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10213505B2 | Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11225523B2 | Triple combination antibody therapies | Emerging Cross-Sectional Technologies | 1 | Active |
| US12152084B2 | Triple combination antibody therapies | Emerging Cross-Sectional Technologies | 0 | Active |
| US11701424B2 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.